We use cookies to display personalized content, analyze site traffic, provide recommendations, and ensure you have a great browsing experience. By continuing to use our site, you consent to our use of cookies. Privacy Policy.
Bringing a new ingredient to market in Australia or New Zealand means meeting strict TGA and FSANZ standards. Our team helps you understand the regulations, prepare your application, and avoid delays. We guide you every step of the way.
If you’re planning to introduce a new ingredient, functional compound, or therapeutic substance in Australia or New Zealand, getting regulatory approval is a key step. We’re here to guide you through the entire process: from checking if your ingredient meets TGA or FSANZ criteria to preparing the right documents and submitting your application. With our support, you’ll understand what’s needed, avoid common delays, and feel confident bringing your product to market.
Regulatory approval for new substances used in therapeutic goods.
Market approval for novel food ingredients.
Identify classification requirements and regulatory pathways.
Comprehensive safety, toxicology, and scientific data compilation.
End-to-end submission support and agency follow-ups.
The Therapeutic Goods Administration (TGA) regulates new substances used in therapeutic goods in Australia. Applications are categorized into four levels based on the type of data available and the extent of evaluation required.
Not sure which category applies to your ingredient? Our experts can assess your data and guide you through the right pathway.
Application Type | Scope | Requirements | Evaluation Timeframe (Working Days) |
IN1 | Existing safety & quality evaluations from Comparable Overseas Bodies (COBs) | Submission of unredacted COB evaluation reports | 70 + 40 (preliminary assessment) |
IN2 | COB safety evaluations; TGA evaluates quality data | COB safety reports and comprehensive quality data | 120 + 40 (preliminary assessment) |
IN3 | COB quality evaluations or recognized monographs; TGA evaluates safety data | COB quality reports or relevant monographs with comprehensive safety data | 150 + 40 (preliminary assessment) |
IN4 | Full de novo evaluation of safety & quality by TGA | Complete safety and quality data packages | 180 + 40 (preliminary assessment) |
Regulatory pathway and commercial considerations, such as importation, biosecurity, and market access.
Preparing toxicology, efficacy, and risk assessment reports.
Managing documentation, agency interactions, and regulatory responses.
A novel food is any food or ingredient without a history of use in Australia and requires assessment by Food Standards Australia New Zealand (FSANZ) to establish its safety before being sold as a food or used in food products. Our services cover:
Assess if your ingredient qualifies as novel.
Compile supporting safety and toxicology data.
Handle FSANZ documentation, progress tracking, and responses.
Assistance with submissions to FSANZ’s Advisory Committee on Novel Foods for a preliminary, non-binding assessment.
A TGA new substance application is required for any new ingredient used in therapeutic goods in Australia. It involves submitting scientific, safety, and efficacy data to meet regulatory requirements.
A novel food is any food or ingredient that does not have a history of significant consumption in Australia or New Zealand. FSANZ assesses novel foods to ensure they are safe before being sold or used in food products. If you are unsure about your ingredient’s status, we can assist with determining its classification.
A FSANZ novel food application requires scientific research, toxicology reports, and safety assessments to demonstrate its suitability for human consumption.
Timelines vary based on the complexity of the application. TGA new substance approvals can take several months, while FSANZ novel food applications typically take between 12 to 24 months for completion.
Yes, we provide end-to-end regulatory support, from determining classification to dossier preparation, submission, and follow-up with regulatory authorities.
Quality Smart Solutions is a global consulting firm, engaged in providing strategic support for products including NHPs, pharmaceuticals, and medical devices, in areas such as Regulatory Support, Site Licensing, Clinical Development and more.
![]() |
Thank you for Signing Up |